Australian Clinical Labs Ltd

AU:ACL Australia Diagnostics & Research
Market Cap
$239.30 Million
AU$386.47 Million AUD
Market Cap Rank
#14607 Global
#190 in Australia
Share Price
AU$2.02
Change (1 day)
+0.00%
52-Week Range
AU$2.02 - AU$3.19
All Time High
AU$5.09
About

Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers range of services, including molecular cancer, harmony NIPT, genetic carrier screening and other antenatal, cardiac, and commercial drug and alcohol testing services; chemical pathology, haematology, histopathology and cytopathology, serology and microbiology, allergy and immunology, and veter… Read more

Australian Clinical Labs Ltd - Asset Resilience Ratio

Latest as of December 2025: 4.11%

Australian Clinical Labs Ltd (ACL) has an Asset Resilience Ratio of 4.11% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
AU$23.14 Million
Cash + Short-term Investments
Total Assets
AU$562.50 Million
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Australian Clinical Labs Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Australian Clinical Labs Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$22.43 Million 3.99%
Short-term Investments AU$703.00K 0.12%
Total Liquid Assets AU$23.14 Million 4.11%

Asset Resilience Insights

  • Limited Liquidity: Australian Clinical Labs Ltd maintains only 4.11% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Australian Clinical Labs Ltd Industry Peers by Asset Resilience Ratio

Compare Australian Clinical Labs Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
ADCNF
OTCGREY:ADCNF
Diagnostics & Research 1.12%
Berry Genomics Co Ltd
SHE:000710
Diagnostics & Research 0.45%
NSN Co. Ltd
KQ:031860
Diagnostics & Research 1.72%
JOONGANG DNM Co.Ltd
KQ:051980
Diagnostics & Research 27.26%
GeneMatrix Inc
KQ:109820
Diagnostics & Research 41.52%
Genoray Co. Ltd
KQ:122310
Diagnostics & Research 0.03%
Green Cross Lab Cell Corporation
KQ:144510
Diagnostics & Research 0.18%
Optipharm.CO.LTD
KQ:153710
Diagnostics & Research 20.73%

Annual Asset Resilience Ratio for Australian Clinical Labs Ltd (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Australian Clinical Labs Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-06-30 3.85% AU$22.12 Million AU$574.84 Million 0.00pp
2024-12-31 3.85% AU$22.12 Million AU$574.84 Million -0.68pp
2024-06-30 4.53% AU$26.84 Million AU$593.06 Million 0.00pp
2023-12-31 4.53% AU$26.84 Million AU$593.06 Million +0.97pp
2023-06-30 3.56% AU$20.59 Million AU$578.91 Million 0.00pp
2022-12-31 3.56% AU$20.59 Million AU$578.91 Million +3.38pp
2022-06-30 0.18% AU$1.13 Million AU$628.04 Million -4.20pp
2021-12-31 4.38% AU$27.51 Million AU$628.04 Million +4.16pp
2021-06-30 0.22% AU$1.05 Million AU$474.70 Million -7.42pp
2020-12-31 7.64% AU$36.28 Million AU$474.70 Million +7.52pp
2020-06-30 0.12% AU$435.00K AU$366.05 Million -9.52pp
2019-12-31 9.64% AU$35.28 Million AU$366.05 Million +8.99pp
2019-06-30 0.65% AU$1.00 Million AU$153.61 Million -2.69pp
2018-12-31 3.34% AU$5.13 Million AU$153.61 Million +0.89pp
2018-06-30 2.45% AU$2.91 Million AU$119.06 Million -5.77pp
2017-12-31 8.22% AU$9.78 Million AU$119.06 Million +7.97pp
2017-06-30 0.25% AU$301.00K AU$120.89 Million -5.82pp
2016-12-31 6.07% AU$7.34 Million AU$120.89 Million --
pp = percentage points